Dymicron, the company developing the Triadyme-C cervical disc, added Peter Wehrly to its board of directors, according to a Feb. 19 news release.
Mr. Wehrly has extensive experience in the medtech industry including president of Premia Spine’s U.S. business, CEO of Vivex Biologics and multiple leadership roles within Medtronic.
“Dymicron’s Triadyme-C technology represents a true leap forward in motion preservation, combining advanced biomechanics with a bearing surface that addresses longstanding wear-debris challenges in cervical arthroplasty,” he said in the release. “The company’s commitment to rigorous clinical validation and global commercialization strongly aligns with my professional focus. I look forward to supporting the leadership team as Dymicron advances toward PMA approval and broadens its global impact.”
